NİHAT FİRAT SİPAHİ, PAYAM AKHYARİ, HUG AUBİN, ARASH MEHDİANİ, SOPHİA ERBEL, RALF WESTENFELD, DANİEL SCHEİBER, HANNAN DALYANOGLU, ARTUR LİCHTENBERG, UDO BOEKEN
Experimental and Clinical Transplantation - 2020;18(4):533-535
Cancer therapy-related cardiotoxicity has been presenting a major problem in cancer survivors, who constitute a growing population caused by a significant improvement in cancer therapy during the past decades. Although some listing criteria have been defined for these patients, it is still a compelling decision to list patients with a complex cancer anamnesis. We describe herein a childhood cancer survivor after a cancer anamnesis with 2 different malignancies and an endstage heart failure following chemoradiotherapy who was successfully treated with orthotopic heart transplant.
